In the heart of Illinois, during my research on wildlife disease, I stumbled upon a shocking discovery: over half of the raccoons I examined were infected with Trypanosoma cruzi, the parasite responsible for causing Chagas disease.
Chagas disease, a neglected tropical illness, is no longer limited to tropical regions. It has made its way to the United States, silently spreading among wildlife. This parasite can lay dormant in the human body for years before manifesting symptoms such as heart failure, stroke, arrhythmias, or even sudden death. The disease is transmitted by triatomine insects, also known as “kissing bugs,” which feed on the blood of infected animals like raccoons, opossums, and rodents. These bugs excrete near their bite, and if their feces come into contact with broken skin or mucous membranes, the parasite can infect humans. In rare cases, Chagas disease has been transmitted through organ transplants, blood transfusions, and congenital exposure.
While Chagas disease is prevalent in Latin America and is a significant public health concern there, it is often overlooked in the United States. The Centers for Disease Control and Prevention estimates that around 300,000 individuals in the U.S. are infected with Trypanosoma cruzi, with many of them being unaware of their condition, particularly those born in endemic regions of Mexico, Central America, and South America.
Contrary to popular belief that this disease primarily affects immigrants or travelers, recent research has shown that T. cruzi is actively circulating in U.S. wildlife. Studies have found infected kissing bugs and mammalian hosts in various states such as Texas, California, Louisiana, and now the Midwest.
Although locally acquired cases of Chagas disease remain relatively rare in the U.S., there is growing concern among researchers that this trend may change. The risk of human contact with infected kissing bugs is higher in areas where homes border wooded landscapes or have features like dog shelters, poultry sheds, or stacked firewood, which provide ideal hiding spots and food sources for these insects. As climate change and land development alter ecosystems, monitoring these risk factors becomes crucial to prevent disease spillover.
Despite the potential threat, the U.S. healthcare system is largely unprepared to deal with Chagas disease. Routine testing is scarce, and most cases are only discovered incidentally, such as during blood donor screenings. Furthermore, there is a misconception that Chagas disease is rare or imported, overlooking the fact that wildlife in the U.S. is already carrying the parasite.
The CDC has provided guidelines on T. cruzi, but there is a significant lack of awareness among healthcare professionals regarding the disease’s domestic relevance. Early detection is key to treating Chagas disease, as antiparasitic medications like benznidazole can be effective if administered promptly.
To address this looming public health threat, awareness campaigns, expanded diagnostic access, targeted screening in high-risk regions, and continued wildlife surveillance are essential. It’s time to acknowledge the presence of Chagas disease in the U.S. and take proactive measures to prevent its spread and impact on human health.
Chagas disease has all the hallmarks of an emerging public health crisis, and it’s crucial that we act with urgency to address it. By underestimating the threat of Chagas disease, we risk facing a potentially larger problem in the future. It’s time to prioritize this issue and treat it as the serious threat it truly is.
Esther Onuselogu, M.Sc., is a research scientist specializing in biological sciences and public health. Her research focuses on Trypanosoma cruzi infection in U.S. wildlife, and she is dedicated to raising awareness about infectious diseases and promoting public health equity.
